LONDON, March 7, 2014 /PRNewswire/ --
On Thursday, March 06, 2014, the
NASDAQ Composite finished at 4,352.13, down 0.13% for the day. The
Dow Jones Industrial Average closed the session at 16,421.89, up
0.38% and the S&P 500 ended the day at 1,877.03, higher by
0.17%. The gains were broad based with 7 of 10 sectors going up.
Investor-Edge.com looks at some of the equities that during the
last session hit a new 52-week high. These include Brocade
Communications Systems Inc.(NASDAQ:BRCD), Huntsman Corporation
(NYSE:HUN), The Kroger Company (NYSE:KR), and Teva Pharmaceutical
Industries Ltd (NYSE:TEVA). Free research on these five companies
can be accessed at:
http://investor-edge.com/register
Brocade Communications Systems Inc.'s stock fluctuated in the
range of $9.99 and $10.29 during Thursday's session, hitting a new
52-week high of $10.29. The company's
stock reported a gain of 1.90%, ending the day at $10.20. A total of 12.76 million shares were
traded, as compared to the 3-months average volume of 5.10 million
shares. Brocade Communications Systems Inc.'s shares have surged
8.51% in the last one month and 18.60% in the previous three
months. The S&P 500 Information Technology Sector Index posted
gains of 1.64% in the previous three trading sessions and 5.85% in
the last three months. Shares of the company traded at a PE ratio
of 14.15 and were up 15.06% on YTD basis. The company's stock is
trading above its 50-day and 200-day moving averages of
$9.32 and $7.79, respectively. The stock's RSI stood at
68.58. Sign up and read the free notes on BRCD at:
http://www.Investor-Edge.com/03072014/BRCD/report.pdf
On Thursday, Huntsman Corp.'s stock finished the day at
$24.59, up 1.11%, hitting a new
52-week high of $25.82. The stock
reported a 3-month average volume of 3.18 million shares compared
with the volume of 11.98 million shares during the session.
Huntsman Corp.'s shares traded at a PE ratio of 18.58 and were down
0.04% on YTD basis. Shares of the company have gained 14.00% in the
last one month and 5.45% in the previous three months. The
Materials Sector Index mapped a gain of 0.36% during the trading
session and charted up by 8.60% during the last one month. The
stock is trading above both its 50-day and 200-day moving averages.
Huntsman Corp.'s 200-day moving average of 20.72 is below the
50-day moving average of $23.15. RSI
of the companywas 65.98 at the end of the session. The
complimentary notes on HUN can be downloaded as in PDF format
at:
http://www.Investor-Edge.com/03072014/HUN/report.pdf
The Kroger Co.'s stock closed the day at $43.37, down 0.71% after hittinga new 52-weeks
high of $45.25. The stock recorded a
trading volume of 12.96 million shares, compared with the 3-month
average volume of 4.31 million shares.The Kroger Co.'s shares are
up 9.71% on YTD basis. Despite Thursday's decline, shares of the
company have advanced 3.29% in the previous three trading sessions
and 7.25% in the last three months. The stock has witnessed a gain
of 17.98% in the last one month. The S&P 500 Consumer Staples
Index mapped a loss of 0.04% during the session and gained 4.58%
during the last one month. The stock is trading above its 50-day
and 200-day moving averages.The Kroger Co.'s 200-day moving average
of $38.72 is above the 50-day moving
average of $38.38. Moreover, the
company's shares were trading at the Relative Strength Index (RSI)
of 83.86. Register for free on Investor-Edge and access the latest
research on KR at:
http://www.Investor-Edge.com/03072014/KR/report.pdf
On Thursday, shares in Teva Pharmaceutical Industries Ltd edged
0.04% higher, to close the day at $49.82, hitting a new 52-week high of
$51.41. The stock recorded a trading
volume of 9.57 million shares, compared with the 3-month average
volumes of 6.61 million shares. It traded between $49.77 and $51.41 during the session. The
company's shares gained 24.30% on YTD basis. Shares of Teva
Pharmaceutical have surged 11.48% in the last one month and 25.65%
in the previous three months. The S&P 500 Health Care sector
Index edged 0.67% lower during the session while the same has
advanced 7.96% during the previous three months. The stock is
trading above its 50-day and 200-day moving averages. Teva
Pharmaceutical Industries Ltd's 200-day moving average of
$40.39 is below the 50-day moving
average of $44.11. Furthermore, the
company's shares were trading at the Relative Strength Index (RSI)
of 70.45. The complete research on TEVA is available for free
at:
http://www.Investor-Edge.com/03072014/TEVA/report.pdf
About Investor-Edge.com
At Investor-Edge, we provide our members with a simple and
reliable way to leverage our economy of scale. Most investors do
not have time to track all publicly traded companies, much less
perform an in-depth review and analysis of the complexities
contained in each situation. That's where Investor-Edge comes in.
We provide a single unified platform for investors' to hear about
what matters. Situation alerts, moving events, and upcoming
opportunities.
=============
EDITOR NOTES:
=============
- This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
- This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
- If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] Investor-edge.com.
- For any urgent concerns or inquiries, please contact us
at compliance [at] Investor-edge.com.
- Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research [at] Investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort
basis. This document, article or report is prepared and authored by
Investor-edge. An outsourced research services provider represented
by Nidhi Vatsal, CFA, has only reviewed the information provided by
Investor-edge in this article or report according to the Procedures
outlined by Investor-edge. Investor-edge is not entitled to veto or
interfere in the application of such procedures by the outsourced
provider to the articles, documents or reports, as the case may
be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or
otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Investor-edge
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Investor-edge expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Investor-edge does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
http://www.Investor-Edge.com
SOURCE Investor-Edge